ReSearch Pharma Files for $100 Million IPO

ReSearch Pharmaceutical Services Inc., a Fort Washington, Penn.-based provider of clinical development services to the biopharmaceutical industry, has filed for a $100 million IPO. It plans to trade on the Nasdaq, with Jefferies & Co. serving as lead underwriter.

The company reports around $224 million in 2009 revenue, up from $175 million in 2008. Its 2009 net income was $2.6 million.

ReSearch Pharma shareholders include Cartesian Capital, The Argentum Group and First Analysis.

Sign up to our Newsletter

Receive updates from our PE HUB Wire and Top Stories of the Week newsletters:

We will not send you spam, and we don't share your email address with 3rd parties.